Unexpected findings at multi-detector CT scans: Less reason to worry

August 27, 2012

A new study from Rhode Island Hospital reports that nearly seven percent of urologic multi-detector computed tomography (MDCT) scans for hematuria result in incidental findings that may be clinically important for the patient. The study is published in the American Journal of Roentgenology.

It is known that urologic CT scans can sometimes show incidental findings. To date, however, there has been limited information about the prevalence and characteristics of those findings. Julie Song, M.D., a radiologist with Rhode Island Hospital's department of diagnostic imaging, is the principal investigator on the study to attempt to classify these findings.

Song says, "We know that incidental findings are common at CT, but such discovery is not always beneficial to the patient. Early detection of treatable disease is desirable, but "incidentalomas" can also be problematic because they can lead to a cascade of additional exams, costs, and added , for many conditions that are ultimately proved to be inconsequential to patient care."

Through a , Song and colleagues examined 1,209 CT scans performed for "hematuria" (blood in the urine). Of the 1,209 patients who had undergone MDCT urography, Song found that nearly 7 percent of the scans resulted in incidental extra-urinary findings that were considered clinically important, and warranting further investigation.

The most common incidental findings were , aneurysms and . But of these, findings that ultimately had significant impact on patient care, such as those requiring immediate medical attention occurred in only 0.9 percent and cancer was found in 0.4 percent.

She concludes, "MDCT urography is a commonly performed study for hematuria. We have shown that significant incidental findings proved to be relatively uncommon."

Explore further: Many radiologists disagree on management of incidental findings, study finds

Related Stories

Many radiologists disagree on management of incidental findings, study finds

November 1, 2011
According to a recent study published in the November issue of the Journal of the American College of Radiology, many radiologists disagree on the management of incidental findings found on body computed tomography (CT) scans. ...

Researchers find little secondary cancer risk from multi-detector CT scans in Medicare population

April 2, 2012
The secondary cancer risk from multi-detector computed tomography (MDCT) scans is low among older adults, according to a study from Stanford University in the April issue of the Journal of the American College of Radiology. ...

Study examines benefit of follow-up CT when abdominal ultrasound inconclusive

April 30, 2012
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.

Recommended for you

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.